Document:

EX-10.1

FIRST AMENDMENT OF EMPLOYMENT AGREEMENT

THIS FIRST AMENDMENT (this “Amendment”), made as of the 19th day of July, 2011 and
effective as of December 31, 2010, of the Employment Agreement, dated as of May 28, 2006 and as
amended and restated as of December 17, 2008 (the “Original Agreement”), by and between
Loral Space & Communications, Inc., a Delaware corporation (hereinafter referred to as the
“Company”) and Michael B. Targoff (the “Executive”);

W I T N E S S E T H:

WHEREAS, Executive has been employed by the Company pursuant to the Original Agreement through the
end of its employment term on December 31, 2010 and thereafter, at will;

WHEREAS, the Company desires to continue to employ Executive subject to the terms of the Original
Agreement retroactive to the expiration of the employment term thereunder, as modified by this
Amendment, and Executive desires to enter into this Amendment and to accept such continued
employment, subject to the terms and provisions of the Original Agreement as modified by this
Amendment.

NOW, THEREFORE, in consideration of the promises and mutual covenants contained herein and for
other good and valuable consideration, the receipt and sufficiency of which are mutually
acknowledged, the Company and the Executive hereby amend the Original Agreement, effective as of
December 31, 2010, as follows:

1. Section 2 of the Original Agreement is hereby amended and restated in its entirety
as follows:

The term of Executive’s employment under this Agreement shall begin as of
March 1, 2006, and, unless sooner terminated as provided in Section 6, shall
conclude on December 31, 2011 (the “Term”).

2. Section 4(a) of the Original Agreement is hereby amended by adding the following
language to the end of the first sentence thereof: “for calendar years prior to 2011, and for
calendar years 2011 and thereafter, at the rate of $1,094,525 per calendar year.”

3. Section 7(c) of the Original Agreement is hereby amended by replacing the third and
fourth sentences thereof with the following:

Following the termination of the Executive’s employment by the Company
without Cause or by the Executive for Good Reason, (i) the Company shall
provide Executive with access to medical and dental coverage, upon the same
terms and conditions generally applicable to similarly situated executives
who remain employed with the Company, for a period of eighteen (18) months;
provided, however, that to the extent the Executive elects to
receive such coverage, the Executive shall be responsible for payment of the
full monthly COBRA premium applicable to such medical and dental coverage
(the “Health Benefits”); and (ii) for eighteen (18) months after the
date of termination of the Executive’s employment by the Company without
Cause or by the Executive for Good Reason, the Company shall pay Executive
each month an amount equal to the excess, if any, of the full monthly COBRA
premiums for such coverage under the Company’s benefit plans under which such
medical and dental coverage is provided, as in effect from time to time, over
the amount of the portion of such premiums Executive would pay if Executive
was an active employee (such payments, the “Continuation Payments”),
which payment shall be paid in advance on the first payroll day of each month
during the such 18-month period, commencing with the month immediately
following the date of termination; provided, however, that
the first such payment shall be made on the date sixty (60) days after the
date of termination, and will include payment of any amounts that were
otherwise due prior thereto; further provided,
however, that the Company’s obligations to provide the Health
Benefits and to make the Continuation Payments shall expire if the Executive
commences new employment prior to the expiration of such eighteen (18)-month
period and becomes covered by substantially similar benefits.

In addition, following the termination of the Executive’s employment by the
Company without Cause or by the Executive for Good Reason, the Company shall
provide Executive with life insurance coverage, upon the same terms and
conditions applicable generally to similarly situated executives who remain
employed with the Company, for a period of eighteen (18) months following the
date of termination; provided, however, that the Executive
shall be responsible for payment of the regular employee portion of the
monthly insurance premiums for such insurance applicable to similarly
situated executives who remain employed with the Company and the Company
shall be responsible for payment of the regular Company portion of the
monthly insurance premium for such insurance applicable to similarly situated
executives who remain employed with the Company (the “Life Insurance
Benefits”); further provided, however, that the
Company’s obligations to provide the Life Insurance Benefits shall expire if
the Executive commences new employment prior to the expiration of such
eighteen (18)-month period and becomes covered by substantially similar
benefits.

Notwithstanding anything herein to the contrary, the Continuation Payments
and the Company portion of the monthly life insurance premiums provided
pursuant to the immediately preceding sentence shall be taxable income to the
Executive in the year in which such Continuation Payments are made and in
which such life insurance coverage is provided, respectively.

4. Section 8 (“280G Gross-Up”) is hereby deleted in its entirety, and the phrase
“[RESERVED]” substituted thereof.

5. Schedule I of the Original Agreement is hereby amended by deleting the reference to
“Executive Medical $4,000.”

6. Except as otherwise set forth herein, the Original Agreement (and, for the avoidance of
doubt, Schedule I thereto) shall remain unchanged and in full force and effect.

[Remainder of Page Intentionally Blank — Signature Page Follows]

1

LORAL SPACE & COMMUNICATIONS INC.

By: /s/ Avi Katz

Name: Avi Katz

Title: Senior Vice President, General Counsel

and Secretary

MICHAEL B. TARGOFF

/s/ Michael B. Targoff

LORAL HOLDINGS CORPORATION (solely for purposes of Section 14(m) hereof)

By: /s/ Avi Katz

Name: Avi Katz

Title: Senior Vice President and Secretary

SPACE SYSTEMS/LORAL, INC. (solely for purposes of Section 14(m) hereof)

By: /s/ Avi Katz

Name: Avi Katz

Title: Senior Vice President and Secretary

2exhibit10_1.htm

  

  

  

** – CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION.  CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS.

 

2011 LIVESTOCK PRODUCTS DISTRIBUTION AGREEMENT

 

This Livestock Products Agreement ("Agreement") effective as of January 1, 2011 ("Effective Date") is made by and between Pfizer Inc., 5 Giralda Farms Madison, New Jersey 07940-1027 ("Pfizer") and MWI Veterinary Supply Company, 651 South Stratford Drive, Suite 100, Meridian, ID 83642 (hereinafter, "MWI").

 

WHEREAS, MWI is in the business of buying and selling animal health products and servicing customers for those products, and

 

WHEREAS, MWI and Pfizer wish to set forth the terms of their relationship related to the purchase and supply of such products,

 

NOW, THEREFORE, in consideration of the promises and covenants contained herein, the parties hereby agree as follows:

 

Definitions:

 

"PARTICIPATING CUSTOMERS" shall mean customers from the list of customers approved by Pfizer who have entered into a Leaders Edge Agreement with Pfizer.

 

"Products" shall mean the Pfizer cattle and swine products sold to MWI by Pfizer pursuant to this Agreement (and referenced in Schedule A to this Agreement).

 

"Sales Out" shall mean the reported sales by MWI to Covansys and accepted by Pfizer.

 

"Strategic Accounts" shall mean all those PARTICIPATING CUSTOMERS listed in Schedule B hereto.

 

1. (a)           Pfizer shall continue to promote its Products to certain select customers in the livestock field. The parties agree that each time a PARTICIPATING CUSTOMER selects MWI as their supplier and to service that customer's account, Pfizer shall send to MWI a Pfizer Suggested Resale Price List which shall specify the Pfizer Products and the Pfizer suggested resale prices quoted to such PARTICIPATING CUSTOMER (hereafter "SUGGESTED RESALE PRICE LIST"). Each such SUGGESTED RESALE PRICE LIST shall be incorporated into and become part of this Agreement. Please find the current SUGGESTED RESALE PRICE LIST listed on Schedule C hereto. Also included on Schedule C is the current Pfizer Livestock Distributor Pricing. The Products and suggested resale prices are subject to change at any time in Pfizer's sole discretion upon thirty (30) days prior written notice.

 

(b) Pfizer reserves the right to add or delete PARTICIPATING CUSTOMERS or Strategic Accounts at any time at Pfizer's sole discretion. Pfizer will provide written notice to MWI of any changes. Pfizer will notify MWI of any (i) additions to the Strategic Accounts list within twenty-four (24) hours of Pfizer's receipt of the customer contract and (ii) removals from the Strategic Accounts list within four (4) business days prior to the removal effective date.

 

2. (a)           MWI represents and warrants that for the purposes of this Agreement, it is in the business of purchasing Products from Pfizer for the sole purpose of resale and distribution, is registered within the state(s) with which it does business, is compliant with all pharmacy and distribution licensing requirements within the state(s) with which it does business, and is compliant with and capable of participating in Electronic Data Interchange (EDI).

 

(b) MWI agrees to purchase from Pfizer, at credit terms agreed to between the parties and as may be further set forth on Pfizer's invoices, Products sufficient to fulfill demand from all customers to whom MWI will sell Products in the quantities desired by the customers.

 

(c) MWI agrees to maintain an inventory of Products equal to /**/ Demand per species as identified on Schedule A Cattle and Swine, but excluding all Products indicated on Schedule A as ineligible for RSA payments. For purposes of this Agreement "Demand" shall mean /**/.

 

All Products shall count towards the amount held in inventory by MWI. MWI and Pfizer agree to act in good faith to resolve any material differences in the on hand inventory calculations.

 

(d) Pfizer reserves the right to allocate purchases such that MWI may not purchase more than two (2) months MWI's average of the most current Moving Annual Total sales purchases. Exceptions must be approved by Pfizer's Animal Health Headquarters.

 

(e) MWI agrees that all sales of Pfizer Products from MWI to a PARTICIPATING CUSTOMER shall reflect the specific prices for each Product provided for in that PARTICIPATING CUSTOMER'S most recent SUGGESTED RESALE PRICE LIST. In the event that the price listed on a PARTICIPATING CUSTOMER'S most recent SUGGESTED RESALE PRICE LIST for any particular Product is lower (at the time of consummation of a sale of such particular Products between MWI and that PARTICIPATING CUSTOMER) than the price paid by MWI to Pfizer for such Product, Pfizer agrees to credit MWI's account for the amount of such difference.

 

3. Nothing herein contained shall create or be deemed to create any relationship between the parties other than as specifically provided for herein. No employment, partnership, specific or general agency relationship shall exist unless specifically provided for in writing between the parties. MWI shall not represent, directly or indirectly, expressly or by implication, that any such relationships exist and/or that MWI has any authority except as set forth in this Agreement.

 

4. MWI shall use commercially reasonable efforts to provide appropriate service to the customers to whom MWI will sell hereunder. For customers serviced pursuant to this Agreement, MWI shall:

 

(a) Store its inventory of Pfizer Products under conditions (including refrigeration where appropriate) in accordance with package labeling or other written instructions from Pfizer to ensure that such Products retain their potency, purity, quality, and identity;

 

(b) Provide to Covansys by the close of business on each day an EDI report 852 report covering all Product inventory purchased from Pfizer and setting forth in dollars at MWI's acquisition cost from Pfizer the amount of inventory by species. MWI agrees that Pfizer shall have the right, upon reasonable advance notice and during business hours to audit inventory in the possession of MWI to confirm compliance with this paragraph 4(b) and to confirm the accuracy of the data contained in the report;

 

(c) Provide to Covansys its Health Industry Number, Customer Health Industry Number, Pfizer Product number, transaction date, ship to zip code, number of units and price with respect to each sale of Product, and unit inventories on each Pfizer Product sku that MWI sells;

 

(d) Provide Sales Out data, which shall include Leaders Edge and Non-Leaders Edge sales, to Covansys within ten (10) working days of the date of each invoice. MWI will use its best efforts to ensure Sales Out data integrity and timeliness;

 

(e) Submit all orders to Pfizer via EDI. EDI report 867 is the acceptable format;

 

(f) Establish any service fee or other charge or discount to any customer including PARTICIPATING CUSTOMERS for Pfizer Products independently and at its sole discretion;

 

(g) Provide regularly scheduled delivery service to its customers and use commercially reasonable efforts to anticipate its customers' requirements for Pfizer Products. In the event Pfizer delivers any product order to PARTICIPATING CUSTOMERS (drop ship), no consideration shall be payable to MWI for that order under paragraph 5 below, provided that Pfizer will pay MWI for any drop ship if such shipment is made necessary by the unavailability of Pfizer Products;

 

(h) MWI agrees that credit limits established by Pfizer shall be subject to change upon written notice by Pfizer in its sole discretion and that no Product shipments will be made to MWI in excess of the established credit limits;

 

(i) Invoice customers in an accurate and timely manner;

 

(j)  Refer to that PARTICIPATING CUSTOMERS SUGGESTED RESALE PRICE LIST on each invoice for Pfizer Products;

 

(k) Take no action, whether or not identified above, that would harm the Goodwill or name of Pfizer, or damage the interests of Pfizer or the Products, other than where supported by sound factual evidence, including, but not limited to, the diversion of Products and statements of false information. For purposes of this Agreement "Goodwill" shall mean the marketplace advantage of customer patronage and loyalty developed with continuous business under the same name over a period of time; and

 

(l) Make payment to Pfizer for all Products purchased from Pfizer /**/. In the event MWI fails to maintain the inventory levels specified in paragraph 2(c) above Pfizer shall have the right, upon /**/ written notice to BUTLER SCHEIN, to receive payment from MWI /**/.

 

5. All sales of Products to PARTICIPATING CUSTOMER or Strategic Accounts for whom a SUGGESTED RESALE PRICE LIST has been incorporated into this Agreement are covered by this Agreement with regard to compensation payable to MWI hereunder. Any transaction involving Products with any customer including a PARTICIPATING CUSTOMER for which MWI has not been selected by that PARTICIPATING CUSTOMER as the distributor are not covered by this Agreement with regard to compensation payable hereunder.

 

6. (a)           MWI shall not be provided with any rebate, discount or other compensation for Products handled under this Agreement unless specifically set forth herein. MWI will NOT be eligible to collect an RSA on any lateral sales to an unauthorized Pfizer distributor. (It is MWI's obligation to confirm with Pfizer, prior to making a sale, as to whether a distributor is an authorized distributor.) All sales by Pfizer to MWI shall be at the then current Pfizer list price but subject to appropriate credits in accordance with paragraph 2(e). Pfizer shall have the right to raise or change the price of any or all Products to MWI on /**/ prior written notice. Pfizer shall be free to limit sales of any or all Products to MWI in advance of any price increase.

 

(b) The parties agree that Pfizer shall not be obligated to issue credits for any returns that exceed the current average of returns of distributors as specified below unless such returns are the subject of a recall or made at the request of Pfizer. The current average of returns of distributors for the calendar year of the contract timeline January 1, 2011 to December 31, 2011 shall be:

 

Distributor Average Returns (credits and exchanges) as a % of sales: /**/

 

7. The payments described in Schedule D hereto constitute full and complete compensation for MWI.

 

8. All returns shall be approved by Pfizer and subject to Pfizer's Returned Goods Policy, attached hereto as Schedule F. MWI may not offset payment to Pfizer of invoice amounts as credit for any compensation payable hereunder. Pfizer shall make bi-monthly payments of appropriate fees to MWI.

 

9. MWI and Pfizer agree that, under the specific circumstances delineated in this Section 9, Pfizer, at Pfizer's sole discretion, may recoup the sums outstanding to it from MWI against those sums which may become due from Pfizer to MWI, in that the obligations arise from mutual transactions. The specific circumstances which will enable Pfizer to initiate recoupment are:

 

(a) MWI becomes insolvent, which shall be defined as:

 

(i) the sum of MWI's debts is greater than all of MWI's property ("Balance Sheet Test"); or

 

(ii) MWI is generally not paying its debts as they come due; or

 

(iii) MWI has failed to act in good faith for a period in excess of six (6) months to resolve any outstanding invoice or purchase order issues or reconciliations.

 

(b) MWI commences a liquidation of its operations by means of a sale of its assets in their entirety or piecemeal; or

 

(c)  MWI ceases its business operations whether or not such cessation is voluntary or involuntary; or;

 

(d) MWI files a proceeding pursuant to the U.S. Bankruptcy Code or any state court proceeding, including an Assignment for the Benefit of Creditors.

 

10. Nothing in this Agreement shall be deemed to preclude MWI from negotiating a service fee or any other consideration from, or providing any discount or rebate to, any customer, including PARTICIPATING CUSTOMERS for any services provided by MWI.

 

11. MWI shall distribute Pfizer Products only under the labeling provided by Pfizer or as otherwise approved in writing by Pfizer; prescribe, recommend, suggest, and advertise each Product for use only under the conditions stated in the labeling provided by Pfizer; and observe all federal, state, and local laws governing the distribution of the Products.

 

12. Nothing in this Agreement shall be deemed to limit Pfizer's ability to sell any Product at any time to any customer including PARTICIPATING CUSTOMERS or any other party. Transactions consummated directly between Pfizer and any such customer or other party shall not qualify for any of the compensation payable to MWI hereunder. Nothing in this Agreement shall be deemed to limit MWI's ability to sell non-Pfizer products at any time to any customer including PARTICIPATING CUSTOMERS or any other party. MWI's active promotion or sale of products not made by Pfizer will not be considered harmful to the Goodwill or name of Pfizer, or the Products, provided that the Pfizer Products are not maligned in any way as prohibited under Section 4(k) of this Agreement.

 

13. EXCEPT AS SET FORTH IN THIS AGREEMENT, IN THE LABELING OF THE PRODUCTS SOLD HEREUNDER, OR AS OTHERWISE SPECIFIED IN WRITING BY PFIZER, PFIZER MAKES NO EXPRESS OR IMPLIED WARRANTIES WITH RESPECT TO THE PRODUCTS.

 

(a) Pfizer shall defend, indemnify, and hold MWI harmless from all liabilities, claims, demands, damages, costs and expenses, or money judgments incurred by MWI or rendered against it resulting from (a) any breach by Pfizer of this Agreement, (b) third party claims or actions for personal injury or property damage which arise out of the distribution or sale of Pfizer products or the failure to warn, except to the extent that such personal injury or property damage arises out of the negligence or willful misconduct of MWI, and (c) any claim that the Products, as sold by Pfizer, were defective. In the event Pfizer is found by any court of competent jurisdiction to be liable for any claim based in products liability, then Pfizer shall reimburse MWI's reasonable legal fees incurred in the course of cooperating with Pfizer's defense. To be covered by this defense and indemnity, MWI must: promptly notify Pfizer of any such claim; allow Pfizer to fully control the defense and/or resolution of the claim; and cooperate fully with Pfizer in the matter. This defense, indemnity and payment for legal fees shall not apply to claims alleging: MWI alteration, negligent handling or improper storage of the Products; sale of outdated Products; sale or recommendation of the Products for uses or in a manner not set forth in either the labeling supplied by Pfizer or as otherwise specified by Pfizer in writing; or sale of the Products after receipt of written notice from Pfizer that such sales should be halted.

 

(b) In no event shall either party be liable to the other party for special, collateral, incidental, punitive or consequential damages in connection with or arising out of this Agreement. Except as provided under subparagraph 13(a), above, total damages recoverable against Pfizer by MWI shall be exclusively limited to the purchase price of the Products with respect to which damages are claimed.

 

14. MWI and Pfizer acknowledge that in the performance of their duties hereunder each may obtain access to "Confidential Information" (as defined below) of the other. MWI and Pfizer agree that during the term of this Agreement and for a period of three (3) years after the termination of this Agreement, unless specifically permitted in writing by the other party, which permission shall not be unreasonably withheld, especially in connection with a sale of all or a substantial portion of MWI's business, to (a) retain in confidence and not disclose to any third party and (b) use only for the purpose of carrying out their duties hereunder, any such Confidential Information. As used herein the term "Confidential Information" means any information, or data, whether of a business or scientific nature and whether in written, oral or tangible form, relating to Pfizer's and MWI's business or potential business or its research and development activities, not generally available to or known to the public, and not otherwise known to the receiving party, that is disclosed to or learned by the other party pursuant hereto. "Confidential information" does not mean or include any information: (a) which is, at the time of disclosure, available to the general public; or (b) which following disclosure becomes available to the general public through no fault of the recipient; or (c) which recipient can demonstrate was in its possession before receipt; or (d) which is disclosed to recipient without restriction on disclosure. Upon written request from either party after completion of the work provided for hereunder or other termination of this Agreement each party will return to the other party any documents, or copies thereof, or any product samples, containing or constituting Confidential Information disclosed to or generated by either party in connection with this Agreement.

 

15. All notices or communications given hereunder by one party to the other shall be sent by  hand or by first class prepaid registered or recorded delivery post or by facsimile addressed to such party as follows:

 

If to Pfizer:

 

Pfizer, Inc.

Attention: President, Animal Health 5 Giralda Farms

Madison, New Jersey 07940 —1027

 

If to MWI:

 

MWI Veterinary Supply Company Attention: President

651 South Stratford Drive

Suite 100

Meridian, ID 83642

 

Either party may change its address by giving written notice to the other party.

 

16. This Agreement shall be effective as of January 1, 2011 and shall continue in force until December 31, 2011. This Agreement may be terminated by either party upon thirty (30) days prior written notice. Such termination may be without cause. This Agreement may be terminated immediately by either party upon written notice in the event of a material breach by the other. In the event MWI takes any action that harms or damages the interests of Pfizer or the Products, other than where supported by sound factual evidence, including, but not limited to, the diversion of Products and statements of false information, Pfizer may terminate this Agreement immediately upon written notice.

 

17. This Agreement shall governed by the laws of the State of New York applicable to contracts made and performed therein. This Agreement is not assignable without the express written consent of the other party, and may be modified or amended only in writing signed by both parties.

 

18. This Agreement and documents referred to herein embody the entire understanding between the parties hereto, will supersede prior agreements relating to the Products. No activities conducted pursuant to this Agreement or related thereto, including but not limited to the future planning activities of the parties, shall be deemed to give rise to any obligations on the part of either party other than as expressly provided for herein.

 

IN WITNESS WHEREOF, intending to be legally bound, the parties have executed this Agreement.

 

	
MWI

	
Pfizer Inc.

	
By:        /s/ Jim Cleary                                                         

Name Jim Cleary

Title President and CEO

Date  December 6, 2010                                                                

	
By:        /s/ Clinton A. Lewis, Jr.                                                         

Clinton A. Lewis, Jr.

President, U.S. Operations

Pfizer Animal Health

Date  December 16, 2010                                                                

 

  

  

  

SCHEDULE A

 

2011 Leaders’ Edge RSA Eligibility List

 

 

	
SKU

	
ITEM DESCRIPTION

	
Rx

	
SIZE

	
RSA

ELIGIBLE

	
RSA

(Sales to LE

Vets & Animal Health

Accounts)

	
RSA

(Sales to

Strategic

Producers)

	
RSA

Sales to

 LE

Producers

	
CATTLE-BIOLOGICALS

	
4252

	
Bovi-Shield® BRSV

	  	
10

	
/**/

	
/**/

	
/**/

	
/**/

	
4256

	
Bovi-Shield BRSV

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
5194

	
Bovi-Shield GOLD® 4

	  	
10

	
/**/

	
/**/

	
/**/

	
/**/

	
5195

	
Bovi-Shield GOLD ® 5

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
5199

	
Bovi-Shield GOLD® 5

	  	
5

	
/**/

	
/**/

	
/**/

	
/**/

	
5196

	
Bovi-Shield GOLD 5

	  	
10

	
/**/

	
/**/

	
/**/

	
/**/

	
5197

	
Bovi-Shield GOLD 5

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
5321

	
Bovi-Shield GOLD ® FP® 5

	  	
10

	
/**/

	
/**/

	
/**/

	
/**/

	
5322

	
Bovi-Shield GOLD FP 5

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
5114

	
Bove-Shield GOLD FP 5 L5

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
5323

	
Bovi-Shield GOLD® FP® 5 L5

	  	
5

	
/**/

	
/**/

	
/**/

	
/**/

	
5324

	
Bovi-Shield GOLD FP 5 L5

	  	
10

	
/**/

	
/**/

	
/**/

	
/**/

	
5325

	
Bovi-Shield GOLD FP 5 L5

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
5116

	
Bovi-Shield GOLD FP 5 VL5

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
5326

	
Bovi-Shield GOLD® FP® 5 VL5

	  	
10

	
/**/

	
/**/

	
/**/

	
/**/

	
5327

	
Bovi-Shield GOLD FP 5 VL5

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
5044

	
Bovi-Shield GOLD® FP® 5 L5 HB

	  	
5

	
/**/

	
/**/

	
/**/

	
/**/

	
5253

	
Bovi-Shield GOLD FP 5 L5 HB

	  	
10

	
/**/

	
/**/

	
/**/

	
/**/

	
5254

	
Bovi-Shield GOLD FP 5 L5 HB

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
5255

	
Bovi-Shield GOLD® FP® 5 VL5 HB

	  	
10

	
/**/

	
/**/

	
/**/

	
/**/

	
5256

	
Bovi-Shield GOLD FP 5 VL5 HB

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
5267

	
Bovi-Shield GOLD® BVD

	  	
10

	
/**/

	
/**/

	
/**/

	
/**/

	
5268

	
Bovi-Shield GOLD BVd

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
5269

	
Bovi-Shield GOLD® IBR-BVD

	  	
10

	
/**/

	
/**/

	
/**/

	
/**/

	
5191

	
Bovi-Shield GOLD IBR-BVD

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
4179

	
Bovi-Shield® IBR

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
4002

	
Calf-Guard®

	  	
1

	
/**/

	
/**/

	
/**/

	
/**/

	
4143

	
CattleMaster® 4+VL5

	  	
5

	
/**/

	
/**/

	
/**/

	
/**/

	
4144

	
CattleMaster 4+VL5

	  	
10

	
/**/

	
/**/

	
/**/

	
/**/

	
4145

	
CattleMaster 4+VL5

	  	
25

	
/**/

	
/**/

	
/**/

	
/**/

	
5094

	
CattleMaster® GOLDTM FP®5

	  	
5

	
/**/

	
/**/

	
/**/

	
/**/

	
5095

	
CattleMaster GOLD FP 5

	  	
10

	
/**/

	
/**/

	
/**/

	
/**/

	
5096

	
CattleMaster GOLD FP 5

	  	
25

	
/**/

	
/**/

	
/**/

	
/**/

	
5124

	
CattleMaster® GOLDTM FP® 5 L5

	  	
5

	
/**/

	
/**/

	
/**/

	
/**/

	
5125

	
CattleMaster GOLD FP 5 L5

	  	
10

	
/**/

	
/**/

	
/**/

	
/**/

	
5126

	
CattleMaster GOLD FP 5 L5

	  	
25

	
/**/

	
/**/

	
/**/

	
/**/

	
1434

	
E.coli Bacterin-J-5TM Strain

	  	
20

	
/**/

	
/**/

	
/**/

	
/**/

	
1435

	
E.coli Bacterin – J-5 Strain

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
5263

	
INFORCETM3

	  	
1

	
/**/

	
/**/

	
/**/

	
/**/

	
5264

	
INFORCE 3

	  	
10

	
/**/

	
/**/

	
/**/

	
/**/

	
5265

	
INFORCE 3

	  	
25

	
/**/

	
/**/

	
/**/

	
/**/

	
5266

	
INFORCE 3

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
4475

	
Leptoferm-5®

	  	
10

	
/**/

	
/**/

	
/**/

	
/**/

	
4477

	
Leptoferm-5

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
4988

	
One Shot®

	  	
5

	
/**/

	
/**/

	
/**/

	
/**/

	
4991

	
One Shot

	  	
10

	
/**/

	
/**/

	
/**/

	
/**/

	
4993

	
One Shot

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
5074

	
One Shot Ultra® 7

	  	
10

	
/**/

	
/**/

	
/**/

	
/**/

	
5075

	
One Shot Ultra 7

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
5076

	
One Shout Ultra® 8

	  	
10

	
/**/

	
/**/

	
/**/

	
/**/

	
5077

	
One Shot Ultra 8

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
5328

	
PregGuard® GOLD FP® 10

	  	
10

	
/**/

	
/**/

	
/**/

	
/**/

	
5329

	
PregGuard GOLD FP 10

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
4308

	
Resvac® 4/Somubac®

	  	
10

	
/**/

	
/**/

	
/**/

	
/**/

	
4307

	
Resvac 4/Somubac

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
5331

	
ScourGuard ® 4K

	  	
10

	
/**/

	
/**/

	
/**/

	
/**/

	
5332

	
ScourGuard 4K

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
5333

	
ScourGuard® 4KC

	  	
10

	
/**/

	
/**/

	
/**/

	
/**/

	
5334

	
ScourGuard 4KC

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
4255

	
Somubac®

	  	
10

	
/**/

	
/**/

	
/**/

	
/**/

	
4254

	
Somubac

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
5088

	
Spirovac®

	  	
10

	
/**/

	
/**/

	
/**/

	
/**/

	
5090

	
Spirovac

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
5200

	
Spirovac® L5

	  	
10

	
/**/

	
/**/

	
/**/

	
/**/

	
5201

	
Spirovac L5

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
5202

	
Spirovac® VL5

	  	
10

	
/**/

	
/**/

	
/**/

	
/**/

	
5203

	
Spirovac VL5

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
4890

	
StayBredTM VL5

	  	
10

	
/**/

	
/**/

	
/**/

	
/**/

	
4892

	
StayBred VL5

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
4904

	
TSV-2®

	  	
1

	
/**/

	
/**/

	
/**/

	
/**/

	
4909

	
TSV-2

	  	
10

	
/**/

	
/**/

	
/**/

	
/**/

	
4912

	
TSV-2

	  	
25

	
/**/

	
/**/

	
/**/

	
/**/

	
4913

	
TSV-2

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
4381

	
Ultrabac® 7

	  	
10

	
/**/

	
/**/

	
/**/

	
/**/

	
4379

	
Ultrabac 7

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
4380

	
Ultrabac 7

	  	
200

	
/**/

	
/**/

	
/**/

	
/**/

	
4384

	
Ultrabac® 7/Somubac®

	  	
10

	
/**/

	
/**/

	
/**/

	
/**/

	
4382

	
Ultrabac 7/Somubac

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
4383

	
Ultrabac 7/Somubac

	  	
200

	
/**/

	
/**/

	
/**/

	
/**/

	
4387

	
Ultrabac-8®

	  	
10

	
/**/

	
/**/

	
/**/

	
/**/

	
4385

	
Ultrabac-8

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
4386

	
Ultrabac-8

	  	
200

	
/**/

	
/**/

	
/**/

	
/**/

	
4388

	
Ultrabac®CD

	  	
10

	
/**/

	
/**/

	
/**/

	
/**/

	
4371

	
Ultrabac CD

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
5062

	
UltraChoice® 7

	  	
10

	
/**/

	
/**/

	
/**/

	
/**/

	
5063

	
UltraChoice 7

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
5064

	
UltraChoice 7

	  	
250

	
/**/

	
/**/

	
/**/

	
/**/

	
5065

	
UltraChoice® 8

	  	
10

	
/**/

	
/**/

	
/**/

	
/**/

	
5066

	
UltraChoice 8

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
5067

	
UltraChoice 8

	  	
250

	
/**/

	
/**/

	
/**/

	
/**/

	
5061

	
UltraChoice® CD

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
4937

	
Vibrin®

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
5330

	
SolidBac® Pinkeye IR/PR®

	  	
1 Pouch of 50

	
/**/

	
/**/

	
/**/

	
/**/

	
5270

	
Salmonella NewPort Bacterial Extract

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
5271

	
Escherichia Coli Bacterial Extract

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
CATTLE-ANTI-INFECTIVES

	
8171

	
A180®

	
Rx

	
100 mL

	
/**/

	
/**/

	
/**/

	
/**/

	
8172

	
A180

	
Rx

	
250 mL

	
/**/

	
/**/

	
/**/

	
/**/

	
8448

	
Albon® Bolus

	  	
5 g x 50

	
/**/

	
/**/

	
/**/

	
/**/

	
8449

	
Albon Bolus

	  	
15 g x 12

	
/**/

	
/**/

	
/**/

	
/**/

	
8450

	
Albon Bolus

	  	
15 g x 50

	
/**/

	
/**/

	
/**/

	
/**/

	
8189

	
Draxxin® Injectable Solution

	
Rx

	
50 mL

	
/**/

	
/**/

	
/**/

	
/**/

	
8174

	
Draxxin Injectable Solution

	
Rx

	
100 mL

	
/**/

	
/**/

	
/**/

	
/**/

	
8175

	
Draxxin Injectable Solution

	
Rx

	
250 mL

	
/**/

	
/**/

	
/**/

	
/**/

	
8176

	
Draxxin Injectable Solution

	
Rx

	
500 mL

	
/**/

	
/**/

	
/**/

	
/**/

	
1506

	
Excede® Sterile Suspension

	
Rx

	
100 mL

	
/**/

	
/**/

	
/**/

	
/**/

	
1431

	
Excenel® RTU Sterile Suspension

	
Rx

	
100 mL

	
/**/

	
/**/

	
/**/

	
/**/

	
7959

	
Liquamycin® LA-200®

	  	
100 mL

	
/**/

	
/**/

	
/**/

	
/**/

	
7960

	
Liquamycin LA-200

	  	
250 mL

	
/**/

	
/**/

	
/**/

	
/**/

	
7961

	
Liquamycin LA-200

	  	
500 mL

	
/**/

	
/**/

	
/**/

	
/**/

	
1465

	
Naxcel® Sterile Powder

	
Rx

	
1 g

	
/**/

	
/**/

	
/**/

	
/**/

	
1466

	
Naxcel Sterile Powder

	
Rx

	
4 g

	
/**/

	
/**/

	
/**/

	
/**/

	
1463

	
Sterile Water

	  	
80 mL

	
/**/

	
/**/

	
/**/

	
/**/

	
1464

	
Sterile Water

	  	
20 mL

	
/**/

	
/**/

	
/**/

	
/**/

	
7948

	
Terramycin® Scour Tabs

	  	
250 mg, 24/btl

	
/**/

	
/**/

	
/**/

	
/**/

	
7949

	
Terramycin Scour Tabs

	  	
250 mg, 100/btl

	
/**/

	
/**/

	
/**/

	
/**/

	
CATTLE-LINCOMIX

	
1453

	
Lincomix® Soluble Powder

	  	
480 g

	
/**/

	
/**/

	
/**/

	
/**/

	
1436

	
Linco-Spectin®

	
Rx

	
20 mL

	
/**/

	
/**/

	
/**/

	
/**/

	
CATTLE-MASTITIS

	
1403

	
Albadry Plus®

	  	
12

	
/**/

	
/**/

	
/**/

	
/**/

	
1404

	
Albadry Plus

	  	
144

	
/**/

	
/**/

	
/**/

	
/**/

	
2004

	
No/**/lvasan® Teat Dip

	  	
1 gal

	
/**/

	
/**/

	
/**/

	
/**/

	
8169

	
Orbeseal®

	  	
144

	
/**/

	
/**/

	
/**/

	
/**/

	
1475

	
Pirsue® Sterile Solution

	
Rx

	
12

	
/**/

	
/**/

	
/**/

	
/**/

	
1476

	
Pirsue Sterile Solution

	
Rx

	
144

	
/**/

	
/**/

	
/**/

	
/**/

	
1480

	
Quatermaster®

	
Rx

	
12

	
/**/

	
/**/

	
/**/

	
/**/

	
1481

	
Quartermaster (Bulk Pack)

	
Rx

	
144

	
/**/

	
/**/

	
/**/

	
/**/

	
1507

	
Spectramast® LC

	
Rx

	
12

	
/**/

	
/**/

	
/**/

	
/**/

	
1510

	
Spectramast LC

	
Rx

	
144

	
/**/

	
/**/

	
/**/

	
/**/

	
1508

	
Spectrmast® DC

	
Rx

	
12

	
/**/

	
/**/

	
/**/

	
/**/

	
1511

	
Spectramast DC

	
Rx

	
144

	
/**/

	
/**/

	
/**/

	
/**/

	
CATTLE-PARACITICIDES

	
7897

	
Dectomax® 1% Injectable

	  	
100 mL

	
/**/

	
/**/

	
/**/

	
/**/

	
8186

	
Dectomax 1% Injectable

	  	
200 mL

	
/**/

	
/**/

	
/**/

	
/**/

	
7899

	
Dectomax 1% Injectable

	  	
500 mL

	
/**/

	
/**/

	
/**/

	
/**/

	
7892

	
Dectomax® Pour-On

	  	
250 mL

	
/**/

	
/**/

	
/**/

	
/**/

	
7893

	
Dectomax Pour-On

	  	
1L

	
/**/

	
/**/

	
/**/

	
/**/

	
7894

	
Dectomax Pour-On

	  	
2.5 L

	
/**/

	
/**/

	
/**/

	
/**/

	
7895

	
Dectomax Pour-On

	  	
5L

	
/**/

	
/**/

	
/**/

	
/**/

	
7030

	
Durasect®

	  	
1 gal

	
/**/

	
/**/

	
/**/

	
/**/

	
7032

	
Durasect® II

	  	
900 mL

	
/**/

	
/**/

	
/**/

	
/**/

	
8783

	
Valbazen®

	  	
500 mL

	
/**/

	
/**/

	
/**/

	
/**/

	
8784

	
Valbazen

	  	
1L

	
/**/

	
/**/

	
/**/

	
/**/

	
8785

	
Valbazen

	  	
5L

	
/**/

	
/**/

	
/**/

	
/**/

	
CATTLE-REPRODUCTION

	
1420

	
EAZI-BreedTM CIDR® Applicator

	  	
Applicator

	
/**/

	
/**/

	
/**/

	
/**/

	
1518

	
EAZI-Breed CIDR Green Applicator

	  	
Applicator

	
/**/

	
/**/

	
/**/

	
/**/

	
1421

	
EAZI-Breed CIDR Insert

	  	
Bag of 10

	
/**/

	
/**/

	
/**/

	
/**/

	
0135

	
EAZI-BreedTM CIDR® G Applicator (Sheep)

	  	
Applicator

	
/**/

	
/**/

	
/**/

	
/**/

	
1533

	
Eazi Breed CIDR G Insert (Sheep)

	  	
Bag of 20

	
/**/

	
/**/

	
/**/

	
/**/

	
2001

	
Factrel®

	
Rx

	
20 mL

	
/**/

	
/**/

	
/**/

	
/**/

	
1455

	
Lutalyse® Sterile Solution

	
Rx

	
30 mL

	
/**/

	
/**/

	
/**/

	
/**/

	
1504

	
Lutalyse Sterile Solution

	
Rx

	
100 mL

	
/**/

	
/**/

	
/**/

	
/**/

	
2003

	
Nolvalube®

	  	
8 lb

	
/**/

	
/**/

	
/**/

	
/**/

	
CATTLE-OTHER PHARMACEUTICALS

	
8152

	
Entrolyte® H.E.

	  	
178 g

	
/**/

	
/**/

	
/**/

	
/**/

	
2002

	
Hog & Cattle Vitamins & Electrolytes

	  	
8 oz

	
/**/

	
/**/

	
/**/

	
/**/

	
1478

	
Predef® 2X

	
Rx

	
100 mL

	
/**/

	
/**/

	
/**/

	
/**/

	
8112

	
Re-Sorb®

	  	
12

	
/**/

	
/**/

	
/**/

	
/**/

	
8142

	
Re-Sorb

	  	
72

	
/**/

	
/**/

	
/**/

	
/**/

	
8620

	
Therabloat®

	  	
2 oz

	
/**/

	
/**/

	
/**/

	
/**/

	
CATTLE-PRODUCTION

	
1458

	
MGA® 200 Premix

	  	
50 lb bag

	
/**/

	
/**/

	
/**/

	
/**/

	
1459

	
MGA® 500 Liquid Premix

	  	
40 lb drum

	
/**/

	
/**/

	
/**/

	
/**/

	
2016

	
Synovex® C

	  	
Box (10-10 ds Clips)

	
/**/

	
/**/

	
/**/

	
/**/

	
2014

	
Synovex C

	  	
Display (20x2-10 ds Clips)

	
/**/

	
/**/

	
/**/

	
/**/

	
2017

	
Synovex ® Choice

	  	
Box (10-10 ds Clips)

	
/**/

	
/**/

	
/**/

	
/**/

	
2018

	
Synovex® H

	  	
Box (10-10 ds Clips)

	
/**/

	
/**/

	
/**/

	
/**/

	
2019

	
Synovex® Plus

	  	
(Box 10-10 ds Clips)

	
/**/

	
/**/

	
/**/

	
/**/

	
2022

	
Synovex® S

	  	
Box (10-10 ds Clips)

	
/**/

	
/**/

	
/**/

	
/**/

	
DAIRY GENOMICS

	
PAG3KDB

	
Brown Swiss 3K Core Traits

	  	
-

	
/**/

	
/**/

	
/**/

	
/**/

	
PAG3KDH

	
Holstein 3K Core Traits

	  	
-

	
/**/

	
/**/

	
/**/

	
/**/

	
PAG3KDJ

	
Jersey 3K Core Traits

	  	
-

	
/**/

	
/**/

	
/**/

	
/**/

	
PAGR

	
Dairy Red Carrier Test

	  	
-

	
/**/

	
/**/

	
/**/

	
/**/

	
BEEF GENOMICS

	
PAGHDA

	
High Density 50 K Angus

	  	
-

	
/**/

	
/**/

	
/**/

	
/**/

	
PAGGST

	
GeneSTAR Combined Panel

	  	
-

	
/**/

	
/**/

	
/**/

	
/**/

	
PAGB

	
GeneSTAR Black

	  	
-

	
/**/

	
/**/

	
/**/

	
/**/

	
GENETIC CONDITIONS

	
PAGDEFAM

	
Arthrogryposis Multiplex

	  	
-

	
/**/

	
/**/

	
/**/

	
/**/

	
PAGDEFNH

	
Neuro Hydrocephalus

	  	
-

	
/**/

	
/**/

	
/**/

	
/**/

	
PAGDEFAMNH

	
AM and NH Combined

	  	
-

	
/**/

	
/**/

	
/**/

	
/**/

	
PAGDEFCA

	
Contractural Arachnodactyly

	  	
-

	
/**/

	
/**/

	
/**/

	
/**/

	
PAGDEFIE

	
Idiopathic Epilepsy

	  	
-

	
/**/

	
/**/

	
/**/

	
/**/

	
PAGDEFMA

	
Alpha-Mannisodosis

	  	
-

	
/**/

	
/**/

	
/**/

	
/**/

	
PAGDEFOS

	
Osteopetrosis

	  	
-

	
/**/

	
/**/

	
/**/

	
/**/

	
PAGDEFPH

	
Pulmonary Hyperplasia Anasarca

	  	
-

	
/**/

	
/**/

	
/**/

	
/**/

	
PAGDEFTH

	
Tibial Hemimelia

	  	
-

	
/**/

	
/**/

	
/**/

	
/**/

	
PAGDEFPHTH

	
PH and TH

	  	
-

	
/**/

	
/**/

	
/**/

	
/**/

	
PARENT VERIFICATION

	
PAGPSNP

	
SireTRACE (SNP)

	  	
-

	
/**/

	
/**/

	
/**/

	
/**/

	
SWINE RESPIRATORY BIOLOGICALS

	
5223

	
FluSure XP®

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
5224

	
FluSure XP

	  	
250

	
/**/

	
/**/

	
/**/

	
/**/

	
5042

	
FluSure® Pandemic

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
5043

	
FluSure Pandemic

	  	
250

	
/**/

	
/**/

	
/**/

	
/**/

	
5219

	
FluSure SP®/FarrowSure® GOLD

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
5220

	
FluSure SP-FarrrowSure GOLD

	  	
250

	
/**/

	
/**/

	
/**/

	
/**/

	
5221

	
FluSure XP®FarrowSure® GOLD Plus B

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
5227

	
FluSure XP®/RespiSure®

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
5231

	
FluSure XP®/RespiSure-ONE®

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
5225

	
FluSure XP®-ER Bac Plus®

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
5233

	
FluSure XP®/RespiSure-ONE®/ER Bac Plus®

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
5001

	
RespiSure-ONE® (to be disc)

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
5002

	
RespiSure-ONE (to be disc)

	  	
250

	
/**/

	
/**/

	
/**/

	
/**/

	
5003

	
RespiSure-ONE (to be disc)

	  	
500

	
/**/

	
/**/

	
/**/

	
/**/

	
5260

	
RespiSure-ONE®

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
5261

	
RespiSure-ONE

	  	
250

	
/**/

	
/**/

	
/**/

	
/**/

	
5262

	
RespiSure-ONE

	  	
500

	
/**/

	
/**/

	
/**/

	
/**/

	
5166

	
RespiSure-ONE®/ER Bac Plus®

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
5167

	
RespiSure-ONE/ER Bac Plus

	  	
250

	
/**/

	
/**/

	
/**/

	
/**/

	
5168

	
RespiSure-ONE/ER Bac Plus

	  	
500

	
/**/

	
/**/

	
/**/

	
/**/

	
4606

	
RespiSure®

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
4618

	
RespiSure

	  	
250

	
/**/

	
/**/

	
/**/

	
/**/

	
4589

	
RespiSure

	  	
500

	
/**/

	
/**/

	
/**/

	
/**/

	
5169

	
RespiSure®/ER Bas Plus®

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
5170

	
RespiSure/ER Bac Plus

	  	
250

	
/**/

	
/**/

	
/**/

	
/**/

	
5171

	
RespiSure/ER Bac Plus

	  	
500

	
/**/

	
/**/

	
/**/

	
/**/

	
2238

	
Suvazyn® RspiFend® MH/HPS

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
2239

	
Syvaxyn RespiFend MH/HPS

	  	
125

	
/**/

	
/**/

	
/**/

	
/**/

	
2224

	
Suvaxyn® PCV2

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
2225

	
Suvaxyn PCV2

	  	
250

	
/**/

	
/**/

	
/**/

	
/**/

	
5041

	
ER BAC® Plus

	  	
250

	
/**/

	
/**/

	
/**/

	
/**/

	
2214

	
Suvaxyn® E - oral

	  	
100

	
/**/

	
/**/

	
/**/

	
/**/

	
2215

	
Suvaxyn E-oral

	  	
250

	
/**/

	
/**/

	
/**/

	
/**/

	
2216

	
Suvaxyn E - oral

	  	
500

	
/**/

	
/**/

	
/**/

	
/**/

	
SWINE REPRODUCTIVE BIOLOGICALS

	
5213

	
ER Bac® L5 GOLD

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
5204

	
FarrowSure® GOLD

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
5248

	
FarrowSure GOLD

	  	
250

	
/**/

	
/**/

	
/**/

	
/**/

	
5206

	
Farrowsure® GOLD B

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
4402

	
LitterGuard®

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
4410

	
LitterGuard® LT-C

	  	
50

	
/**/

	
/**/

	
/**/

	
/**/

	
4452

	
LitterGuard LT-C

	  	
250

	
/**/

	
/**/

	
/**/

	
/**/

	
SWINE LARGE ANIMAL VIALS

	
8189

	
Draxxin® Injectable Solution

	
Rx

	
50 mL

	
/**/

	
/**/

	
/**/

	
/**/

	
8174

	
Draxxin Injectable Solution

	
Rx

	
100 mL

	
/**/

	
/**/

	
/**/

	
/**/

	
8175

	
Draxxin Injectable Solution

	
Rx

	
250 mL

	
/**/

	
/**/

	
/**/

	
/**/

	
8176

	
Draxxin Injectable Solution

	
Rx

	
500 mL

	
/**/

	
/**/

	
/**/

	
/**/

	
1505

	
EXCEDE® for Swine

	
Rx

	
100 mL

	
/**/

	
/**/

	
/**/

	
/**/

	
1431

	
Excenel® RTU Sterile Suspension

	
Rx

	
100 mL

	
/**/

	
/**/

	
/**/

	
/**/

	
1436

	
Linco-Spectin®

	
Rx

	
20 mL

	
/**/

	
/**/

	
/**/

	
/**/

	
1450

	
Lincomix® 100 mg Injectable

	  	
100 mL

	
/**/

	
/**/

	
/**/

	
/**/

	
1451

	
Lincomix 300 mg Injectable

	  	
100 mL

	
/**/

	
/**/

	
/**/

	
/**/

	
1455

	
Lutalyse® Sterile Solution

	
Rx

	
30 mL

	
/**/

	
/**/

	
/**/

	
/**/

	
1504

	
Lutalyse Sterile Solution

	
Rx

	
100 mL

	
/**/

	
/**/

	
/**/

	
/**/

	
1465

	
Naxcel® Sterile Powder

	
Rx

	
1 g

	
/**/

	
/**/

	
/**/

	
/**/

	
1466

	
Naxcel Sterile Powder

	
Rx

	
4 g

	
/**/

	
/**/

	
/**/

	
/**/

	
1463

	
Sterile Water

	  	
80 mL

	
/**/

	
/**/

	
/**/

	
/**/

	
1478

	
Predef® 2X

	
Rx

	
100 mL

	
/**/

	
/**/

	
/**/

	
/**/

	
7897

	
Dectomax® 1% Injectable

	  	
100 mL

	
/**/

	
/**/

	
/**/

	
/**/

	
8186

	
Dectomax 1% Injectable

	  	
200 mL

	
/**/

	
/**/

	
/**/

	
/**/

	
7899

	
Dectomax 1% Injectable

	  	
500 mL

	
/**/

	
/**/

	
/**/

	
/**/

	
7959

	
Liquamycin® LA-200®

	  	
100 mL

	
/**/

	
/**/

	
/**/

	
/**/

	
7960

	
Liquamycin LA-200

	  	
250 mL

	
/**/

	
/**/

	
/**/

	
/**/

	
7961

	
Liquamycin LA-200

	  	
500 mL

	
/**/

	
/**/

	
/**/

	
/**/

	
1453

	
Lincomix® Soluble Powder

	  	
480 g

	
/**/

	
/**/

	
/**/

	
/**/

	
1454

	
LS 50

	  	
75 g

	
/**/

	
/**/

	
/**/

	
/**/

	
SWINE-FEED MEDICATIONS

	
1447

	
Lincomix® 20

	  	
50 lb

	
/**/

	
/**/

	
/**/

	
/**/

	
1448

	
Lincomix® 50

	  	
50 lb

	
/**/

	
/**/

	
/**/

	
/**/

 

 

  

  

  

LIST OF STRATEGIC ACCOUNTS

 

"PARTICIPATING CUSTOMERS (Veterinarians, Dealers, Producers, and Strategic Producers) will be clearly identified with current updates within the Leaders' Edge Enrollment Notifications that are regularly posted to the Pfizer AH Partners website

 

www.pfizerhartners.com.

 

	
NARC Id

	
Company Name

	
Address

	
City

	
State

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

	
/**/

 

 

 

 

  

  

  

SCHEDULE C

 

  

  

  

 

 

CONFIDENTIAL

 

EFFECTIVE FEBRUARY 1, 2011 - DECEMBER 31, 2011

 

	
ITEM NUMBER

	
 

ITEM DESCRIPTION

	
 

SIZE

	
CASE QUANTITY

	
DISTRIBUTOR PRICE

	
RETURN GOODS PRICE

	
BIOLOGICALS

	  
	
4252

	
Bovi-Shield® BRSV

	
10

	
100

	
/**/

	
/**/

	
4256

	
Bovi-Shield BRSV

	
50

	
20

	
/**/

	
/**/

	
5194

	
Bovi-Shield GOLD® 4

	
10

	
100

	
/**/

	
/**/

	
5195

	
Bovi-Shield GOLD 4

	
50

	
20

	
/**/

	
/**/

	
5199

	
Bovi-Shield GOLD® 5

	
5

	
200

	
/**/

	
/**/

	
5196

	
Bovi-Shield GOLD 5

	
10

	
100

	
/**/

	
/**/

	
5197

	
Bovi-Shield GOLD 5

	
50

	
20

	
/**/

	
/**/

	
5321

	
Bovi-Shield GOLD® FP® 5

	
10

	
100

	
/**/

	
/**/

	
5322

	
Bovi-Shield GOLD FP 5

	
50

	
20

	
/**/

	
/**/

	
5323

	
Bovi-Shield GOLD® FP® 5 L5

	
5

	
200

	
/**/

	
/**/

	
5324

	
Bovi-Shield GOLD FP 5 L5

	
10

	
100

	
/**/

	
/**/

	
5325

	
Bovi-Shield GOLD FP 5 L5

	
50

	
20

	
/**/

	
/**/

	
5326

	
Bovi-Shield GOLD® FP® 5 VL5

	
10

	
100

	
/**/

	
/**/

	
5327

	
Bovi-Shield GOLD FP 5 VL5

	
50

	
20

	
/**/

	
/**/

	
5044

	
Bovi-Shield GOLD® FP® 5 L5 HB

	
5

	
200

	
/**/

	
/**/

	
5253

	
Bovi-Shield GOLD FP 5 L5 HB

	
10

	
100

	
/**/

	
/**/

	
5254

	
Bovi-Shield GOLD FP 5 L5 HB

	
50

	
20

	
/**/

	
/**/

	
5255

	
Bovi-Shield GOLD® FP® 5 VL5 HB

	
10

	
40

	
/**/

	
/**/

	
5256

	
Bovi-Shield GOLD FP 5 VL5 HB

	
50

	
20

	
/**/

	
/**/

	
5267

	
Bovi-Shield GOLD® BVD

	
10

	
100

	
/**/

	
/**/

	
5268

	
Bovi-Shield GOLD BVD

	
50

	
20

	
/**/

	
/**/

	
5269

	
Bovi-Shield GOLD® IBR-BVD

	
10

	
100

	
/**/

	
/**/

	
5191

	
Bovi-Shield GOLD IBR-BVD

	
50

	
20

	
/**/

	
/**/

	
4179

	
Bovi-Shield® IBR

	
50

	
20

	
/**/

	
/**/

	
4002

	
Calf-Guard®

	
1

	
750

	
/**/

	
/**/

	
4143

	
CattleMaster® 4+VL5

	
5

	
100

	
/**/

	
/**/

	
4144

	
CattleMaster 4+VL5

	
10

	
40

	
/**/

	
/**/

	
4145

	
CattleMaster 4+VL5

	
25

	
40

	
/**/

	
/**/

	
5094

	
CattleMaster® GOLDTM FP® 5

	
5

	
100

	
/**/

	
/**/

	
5095

	
CattleMaster GOLD FP 5

	
10

	
40

	
/**/

	
/**/

	
5096

	
CattleMaster GOLD FP 5

	
25

	
40

	
/**/

	
/**/

	
5124

	
CattleMaster® GOLDTM FP® 5 L5

	
5

	
100

	
/**/

	
/**/

	
5125

	
CattleMaster GOLD FP 5 L5

	
10

	
40

	
/**/

	
/**/

	
5126

	
CattleMaster GOLD FP 5 L5

	
25

	
40

	
/**/

	
/**/

	
1434

	
E.coli Bacterin- J-5TM Strain

	
20

	
42

	
/**/

	
/**/

	
1435

	
E.coli Bacterin- J-5 Strain

	
50

	
36

	
/**/

	
/**/

	
5263

	
INFORCETM3

	
1

	
750

	
/**/

	
/**/

	
5264

	
INFORCE 3

	
10

	
100

	
/**/

	
/**/

	
5265

	
INFORCE 3

	
25

	
40

	
/**/

	
/**/

	
5266

	
INFORCE 3

	
50

	
20

	
/**/

	
/**/

	
4475

	
Leptoferm-5®

	
10

	
100

	
/**/

	
/**/

	
4477

	
Leptoferm-5

	
50

	
100

	
/**/

	
/**/

	
4988

	
One Shot®

	
5

	
200

	
/**/

	
/**/

	
4991

	
One Shot

	
10

	
100

	
/**/

	
/**/

	
4993

	
One Shot

	
50

	
20

	
/**/

	
/**/

	
5074

	
One Shot Ultra® 7

	
10

	
100

	
/**/

	
/**/

	
5075

	
One Shot Ultra 7

	
50

	
20

	
/**/

	
/**/

	
Pfizer reserves the right to modify or discontinue this pricing at any time and for any reason

	
 

  

  

  

 

CONFIDENTIAL

 

EFFECTIVE FEBRUARY 1, 2011 - DECEMBER 31, 2011

 

	
ITEM NUMBER

	
 

ITEM DESCRIPTION

	
 

SIZE

	
 

CASE   QUANTITY

	
DISTRIBUTOR PRICE

	
RETURN GOODS PRICE

	
BIOLOGICALS

	  	  
	
5076

	
One Shot Ultra® 8

	
10

	
100

	
/**/

	
/**/

	
5077

	
One Shot Ultra 8

	
50

	
20

	
/**/

	
/**/

	
5328

	
PregGuard® GOLD FP® 10

	
10

	
100

	
/**/

	
/**/

	
5329

	
PregGuard GOLD FP 10

	
50

	
20

	
/**/

	
/**/

	
4308

	
Resvac® 4/Somubac®

	
10

	
100

	
/**/

	
/**/

	
4307

	
Resvac 4/Somubac

	
50

	
20

	
/**/

	
/**/

	
5331

	
ScourGuard® 4K

	
10

	
100

	
/**/

	
/**/

	
5332

	
ScourGuard 4K

	
50

	
100

	
/**/

	
/**/

	
5333

	
ScourGuard® 4KC

	
10

	
100

	
/**/

	
/**/

	
5334

	
ScourGuard 4KC

	
50

	
100

	
/**/

	
/**/

	
4255

	
Somubac®

	
10

	
100

	
/**/

	
/**/

	
4254

	
Somubac

	
50

	
100

	
/**/

	
/**/

	
5088

	
Spirovac®

	
10

	
100

	
/**/

	
/**/

	
5090

	
Spirovac

	
50

	
100

	
/**/

	
/**/

	
5200

	
Spirovac® L5

	
10

	
100

	
/**/

	
/**/

	
5201

	
Spirovac L5

	
50

	
100

	
/**/

	
/**/

	
5202

	
Spirovac® VL5

	
10

	
80

	
/**/

	
/**/

	
5203

	
Spirovac VL5

	
50

	
20

	
/**/

	
/**/

	
4890

	
StayBredTM VL5

	
10

	
100

	
/**/

	
/**/

	
4892

	
StayBred VL5

	
50

	
100

	
/**/

	
/**/

	
4904

	
TSV-2®

	
1

	
750

	
/**/

	
/**/

	
4909

	
TSV-2

	
10

	
100

	
/**/

	
/**/

	
4912

	
TSV-2

	
25

	
40

	
/**/

	
/**/

	
4913

	
TSV-2

	
50

	
20

	
/**/

	
/**/

	
4381

	
Ultrabac® 7

	
10

	
192

	
/**/

	
/**/

	
4379

	
Ultrabac 7

	
50

	
48

	
/**/

	
/**/

	
4380

	
Ultrabac 7

	
200

	
12

	
/**/

	
/**/

	
4384

	
Ultrabac® 7/Somubac®

	
10

	
192

	
/**/

	
/**/

	
4382

	
Ultrabac 7/Somubac

	
50

	
48

	
/**/

	
/**/

	
4383

	
Ultrabac 7/Somubac

	
200

	
12

	
/**/

	
/**/

	
4387

	
Ultrabac-8®

	
10

	
192

	
/**/

	
/**/

	
4385

	
Ultrabac-8

	
50

	
48

	
/**/

	
/**/

	
4386

	
Ultrabac-8

	
200

	
12

	
/**/

	
/**/

	
4388

	
Ultrabac® CD

	
10

	
100

	
/**/

	
/**/

	
4371

	
Ultrabac CD

	
50

	
100

	
/**/

	
/**/

	
5062

	
UltraChoice® 7

	
10

	
100

	
/**/

	
/**/

	
5063

	
UltraChoice 7

	
50

	
100

	
/**/

	
/**/

	
5064

	
UltraChoice 7

	
250

	
12

	
/**/

	
/**/

	
Pfizer reserves the right to modify or discontinue this pricing at any time and for any reason

	
 

  

  

  

 

CONFIDENTIAL

 

EFFECTIVE FEBRUARY 1, 2011 - DECEMBER 31, 2011

 

	
ITEM NUMBER

	
 

ITEM DESCRIPTION

	
 

SIZE

	
 

CASE   QUANTITY

	
DISTRIBUTOR PRICE

	
RETURN GOODS PRICE

	
BIOLOGICALS

	  	  
	
5065

	
UltraChoice® 8

	
10

	
100

	
/**/

	
/**/

	
5066

	
UltraChoice 8

	
50

	
100

	
/**/

	
/**/

	
5067

	
UltraChoice 8

	
250

	
12

	
/**/

	
/**/

	
5061

	
UltraChoice® CD

	
50

	
100

	
/**/

	
/**/

	
4937

	
Vibrin®

	
50

	
100

	
/**/

	
/**/

	
5330

	
SolidBac® Pinkeye IR/PR®

	
1 Pouch of 50

	
20 Pouches of 50

	
/**/

	
/**/

	
5270

	
Salmonella Newport Bacterial Extract

	
50

	
72

	
/**/

	
/**/

	
5271

	
Escherichia Coli Bacterial Extract

	
50

	
72

	
/**/

	
/**/

	
ANTI-INFECTIVES

	  	  
	
8171

	
A180®                                           Rx

	
100 mL

	
12

	
/**/

	
/**/

	
8172

	
A180                                           Rx

	
250 mL

	
6

	
/**/

	
/**/

	
8448

	
Albon® Bolus

	
5 g x 50

	
12

	
/**/

	
/**/

	
8449

	
Albon Bolus

	
15 g x 12

	
12

	
/**/

	
/**/

	
8450

	
Albon Bolus

	
15 g x 50

	
6

	
/**/

	
/**/

	
8189

	
Draxxin® Injectable Solution Rx

	
50 mL

	
40

	
/**/

	
/**/

	
8174

	
Draxxin Injectable Solution Rx

	
100 mL

	
12

	
/**/

	
/**/

	
8175

	
Draxxin Injectable Solution Rx

	
250 mL

	
6

	
/**/

	
/**/

	
8176

	
Draxxin Injectable Solution Rx

	
500 mL

	
6

	
/**/

	
/**/

	
1506

	
Excede® Sterile Suspension Rx

	
100 mL

	
10

	
/**/

	
/**/

	
1431

	
Excenel® RTU Sterile Suspension Rx

	
100 mL

	
10

	
/**/

	
/**/

	
7959

	
Liquamycin® LA-200®

	
100 mL

	
24

	
/**/

	
/**/

	
7960

	
Liquamycin LA-200

	
250 mL

	
12

	
/**/

	
/**/

	
7961

	
Liquamycin LA-200

	
500 mL

	
6

	
/**/

	
/**/

	
1465

	
Naxcel® Sterile Powder                                           Rx

	
1 g

	
48

	
/**/

	
/**/

	
1466

	
Naxcel Sterile Powder                                           Rx

	
4 g

	
36

	
/**/

	
/**/

	
1463

	
Sterile Water

	
80 mL

	
72

	
/**/

	
/**/

	
1464

	
Sterile Water

	
20 mL

	
288

	
/**/

	
/**/

	
7948

	
Terramycin® Scour Tabs

	
250 mg, 24/btl

	
12

	
/**/

	
/**/

	
7949

	
Terramycin Scour Tabs

	
250 mg, 100/btl

	
12

	
/**/

	
/**/

	
LINCOMIX

	  	  
	
1453

	
Lincomix Soluble Powder

	
480 g

	
5

	
/**/

	
/**/

	
1436

	
Linco-Spectin®                                           Rx

	
20 mL

	
72

	
/**/

	
/**/

	
MASTITIS

	  	  
	
1403

	
Albadry Plus® **

	
Box (12 syringes)

	
12

	
/**/

	
/**/

	
1404

	
Albadry Plus **

	
Pail (144 syringes)

	
1

	
/**/

	
/**/

	
2004

	
Nolvasan® Teat Dip

	
1 gal

	
4

	
/**/

	
/**/

	
8169

	
Orbeseal®

	
Pail (144 syringes)

	
1

	
/**/

	
/**/

	
1475

	
Pirsue® Sterile Solution                                           Rx

	
Box (12 syringes)

	
12

	
/**/

	
/**/

	
1476

	
Pirsue Sterile Solution                                           Rx

	
Pail (144 syringes)

	
1

	
/**/

	
/**/

	
1480

	
Quartermaster®                                           Rx

	
Box (12 syringes)

	
12

	
/**/

	
/**/

	
1481

	
Quartermaster (Bulk Pack) Rx

	
Pail (144 syringes)

	
1

	
/**/

	
/**/

	
1507

	
Spectramast® LC                                           Rx

	
Box (12 syringes)

	
12

	
/**/

	
/**/

	
1510

	
Spectramast LC                                           Rx

	
Pail (144 syringes)

	
1

	
/**/

	
/**/

	
1508

	
Spectramast® DC                                           Rx

	
Box (12 syringes)

	
12

	
/**/

	
/**/

	
1511

	
Spectramast DC                                           Rx

	
Pail (144 syringes)

	
1

	
/**/

	
/**/

	
Pfizer reserves the right to modify or discontinue this pricing at any time and for any reason

	
 

  

  

  

 

CONFIDENTIAL

 

EFFECTIVE FEBRUARY 1, 2011 - DECEMBER 31, 2011

 

	
ITEM NUMBER

	
 

ITEM DESCRIPTION

	
 

SIZE

	
 

CASE   QUANTITY

	
DISTRIBUTOR PRICE

	
RETURN GOODS PRICE

	
PARASITICIDES

	  	  
	
7897

	
Dectomax® 1% Injectable

	
100 mL

	
24

	
/**/

	
/**/

	
8186

	
Dectomax 1% Injectable

	
200 mL

	
12

	
/**/

	
/**/

	
7899

	
Dectomax 1% Injectable

	
500 mL

	
6

	
/**/

	
/**/

	
7892

	
Dectomax® Pour-On

	
250 mL

	
10

	
/**/

	
/**/

	
7893

	
Dectomax Pour-On

	
1 L

	
10

	
/**/

	
/**/

	
7894

	
Dectomax Pour-On

	
2.5 L

	
4

	
/**/

	
/**/

	
7895

	
Dectomax Pour-On

	
5 L

	
2

	
/**/

	
/**/

	
7030

	
Durasect®

	
1 gal

	
4

	
/**/

	
/**/

	
7032

	
Durasect II

	
900 mL

	
6

	
/**/

	
/**/

	
8783

	
Valbazen®

	
500 mL

	
12

	
/**/

	
/**/

	
8784

	
Valbazen

	
1 L

	
12

	
/**/

	
/**/

	
8785

	
Valbazen

	
5 L

	
2

	
/**/

	
/**/

	  	
REPRODUCTION

	  	  	  	  
	
1421

	
EAZI-Breed CIDR Insert

	
Bag of 10

	
50 Bags of 10

	
/**/

	
/**/

	
1420

	
EAZI-BreedTM CIDR® Applicator §

	
Applicator

	
50

	
/**/

	
/**/

	
1518

	
EAZI-Breed CIDR Green Applicator §

	
Applicator

	
50

	
/**/

	
/**/

	
1533

	
EAZI-Breed CIDR G Insert (Sheep)

	
Bag of 20

	
5 Bags of 20

	
/**/

	
/**/

	
0135

	
EAZI-BreedTM CIDR® G Applicator (Sheep) §

	
Applicator

	
100

	
/**/

	
/**/

	
2001

	
Factrel®

	
20 mL

	
24

	
/**/

	
/**/

	
1455

	
Lutalyse® Sterile Solution Rx

	
30 mL

	
48

	
/**/

	
/**/

	
1504

	
Lutalyse Sterile Solution                                           Rx

	
100 mL

	
10

	
/**/

	
/**/

	
2003

	
Nolvalube®

	
8 lb

	
4

	
/**/

	
/**/

	
PRODUCTION

	  	  
	
1458

	
MGA® 200 Premix

	
50 lb Bag

	
1

	
/**/

	
/**/

	
1459

	
MGA® 500 Liquid Premix

	
40 lb Drum

	
1

	
/**/

	
/**/

	
2016

	
Synovex® C

	
Box(10-10 ds Clips)

	
50

	
/**/

	
/**/

	
 

2014

	
 

Synovex C

	
Display

(20 Boxes x 2-10 ds Clips)

	
10

	
/**/

	
/**/

	
2017

	
Synovex® Choice

	
Box(10-10 ds Clips)

	
50

	
/**/

	
/**/

	
2018

	
Synovex® H

	
Box(10-10 ds Clips)

	
50

	
/**/

	
/**/

	
2019

	
Synovex® Plus

	
Box(10-10 ds Clips)

	
10

	
/**/

	
/**/

	
2022

	
Synovex® S

	
Box(10-10 ds Clips)

	
50

	
/**/

	
/**/

	
OTHER PHARMACEUTICALS

	  	  
	
8152

	
Entrolyte® H.E.

	
178 g

	
40

	
/**/

	
/**/

	
2002

	
Hog & Cattle Vitamins & Electrolytes

	
8 oz

	
40

	
/**/

	
/**/

	
1478

	
Predef® 2X                                           Rx

	
100 mL

	
6

	
/**/

	
/**/

	
8112

	
Re-Sorb®

	
12

	
6

	
/**/

	
/**/

	
8142

	
Re-Sorb

	
72

	
1

	
/**/

	
/**/

	
8620

	
Therabloat®

	
2 oz

	
144

	
/**/

	
/**/

	
2012

	
Rodenticide - Ropax Bars Bulk Pail

	
Pail

	
4

	
/**/

	
/**/

	
2011

	
Rodenticide - Ropax Bait Pack Pallets

	
80 ct

	
4

	
/**/

	
/**/

 

* Synovex C display pricing shown for informational purposes only.

 

§ Item may be received for free with a qualifying purchase.

 

** See Pfizer sales rep for details on a current Albadry promotion.

 

Pfizer  reserves the right to modify or discontinue  this pricing at any time and for any reason. Case quantities are subject to change.

	
Pfizer reserves the right to modify or discontinue this pricing at any time and for any reason

	
 

  

  

  

SCHEDULE D

 

Section A

 

Fee for Logistics

 

	
  

	
Definitions:

	
"Fee Eligible Products" shall mean those Pfizer Products listed in Schedule A hereto for which a Fee payment will be made to MWI in accordance with paragraph 5.

 

1)           Pfizer shall pay to MWI a fee for logistics (hereinafter, "Fee") paid at a rate of (i) a differentiated percentage [see SCHEDULE E for breakdown] on Sales Out for Fee Eligible Products to identified PARTICIPATING CUSTOMERS who are producers (but not including Strategic Accounts), (ii) /**/ on Sales Out for Fee Eligible Products to identified PARTICIPATING CUSTOMERS who are veterinarians (but not including Strategic Accounts), and (iii) /**/ on Sales Out for Fee Eligible Products to identified PARTICIPATING CUSTOMERS who are Strategic Accounts. For a Veterinarian to receive an RSA on Strategic Producer product sales, the Veterinarian must buy those product quantities directly from Pfizer Animal Health. Such product purchases must be made within the timeframe of the reported sales to the Strategic Producer in order to receive a /**/ for sales to Leaders' Edge Strategic Producers. The Veterinarian also must hold the accounts receivable on those products for the Strategic Producer. The remaining product purchases to service Leaders' Edge accounts or Non-Leaders' Edge accounts may be sourced from an authorized Pfizer distributor or directly from Pfizer Animal Health. The Fee is calculated on a Product by Product basis and based on the Product price contained in the Participating Customer's SUGGESTED RESALE PRICE LIST in effect at the time of such Product purchase. The Fee is contingent on MWI fulfilling all conditions outlined in paragraph 4 of this Agreement. The payments made pursuant to this Schedule D, Section A are not payable for sales to anyone other than PARTICIPATING CUSTOMERS. The Fee is net of any difference between MWI's purchase price and the SUGGESTED RESALE PRICE LIST price. MWI shall only receive the payments set out in this Schedule D, Section A for sales to PARTICIPATING CUSTOMERS which are consummated after confirmation by Pfizer to MWI that a customer is a PARTICIPATING CUSTOMER.

 

2)           Pfizer shall have the right to audit shipping records of MWI to confirm delivery of Products to producers or veterinarians in order to assure proper Fee payments under paragraph 1 of this Schedule D, Section A. Any material misrepresentations by MWI related to paragraph 1 of this Schedule D, Section A and the party actually taking possession of the products shall void any payments due under paragraph 1 of this Schedule D, Section A. In addition, MWI recognizes that the Leaders Edge program is designed as an effective go-to market approach to selling for the benefit of veterinarians and/or dealers who add value in the transaction to their customers as well as value for those customers. Blatant abuse of the intended structure of the Leaders Edge Program by MWI (including, but not limited to, falsification of EDI data or establishing false business entities or inserting business entities that add no commercial value to end users purely to obtain additional Fee payments) will subject MWI to potential forfeiture of all Fee's paid on those transactions provided for in this Schedule D, Section A at the sole discretion of Pfizer. Decisions made as a result of Pfizer's investigations of blatant abuse of the intended structure of Leaders Edge are solely Pfizer's to make and forfeitures of Fees may happen retroactively in the form of credits against future Fee payments.

 

3)           The parties agree that MWI will provide to Pfizer on request and within two (2) business days, proof of delivery on any suspicious (as determined by Pfizer) EDI transaction. MWI agrees that Pfizer shall be entitled to audit, either directly or through external auditors hired by Pfizer and upon reasonable notice by Pfizer, MWI's books and records for the purpose of determining the accuracy of EDI data for Pfizer Product sales communicated to Pfizer through Covansys.

 

4)           Products which are not listed in Schedule A do not qualify for Fee payments. All such Products shall be purchased by MWI on a buy sell basis. If new sku's are added to Schedule A, Pfizer will communicate this to MWI on a quarterly basis.

 

 

 

 

  

  

  

SCHEDULE E

 

Cattle Swine Leaders Edge/Differentiated RSA

 

Effective January 1, 2011 through December 31, 2011 Leaders' Edge Suppliers will receive a service fee (RSA) for sales to eligible Leaders' Edge customers as indicated below.

 

RSA Payments

 

 

 

 

	
Sales to ->

	
LE Vet/Dealer

	
LE Strategic

Producer

	
LE Producer

	
Distributor

	
/**/

	
/**/

	
Variable RSA (See Schedule A)

	
Veterinarian

	
/**/

	
/**/

	
Variable RSA (See Schedule A)

 

** Veterinarians MUST purchase an equivalent amount of product direct from Pfizer Animal Health to be eligible for a /**/ for sales to Leaders' Edge Strategic Producers.

 

 

 

  

  

  

SCHEDULE F

 

Pfizer Returned Goods Policy & Procedure

 

AUDIENCE

 

Customer Service Operations, Finance, Marketing, & Field Force

 

SCOPE

 

Cattle, Swine, Equine, and CAD products purchased directly from Pfizer Animal Health may be returned for credit based on the current Pfizer Animal Health Return Goods Price List providing it is not outside the defined return window. ONLY CAD products may be returned for exchange providing it is not outside the defined return window.

 

	
  

	
o

	
Cattle, Swine, Equine, and CAD products return window is defined as two months prior and six months beyond the product's expiration date. (except Revolution 6pk and Rimadyl 180ct, which can be exchanged or credited six months prior to the products expiration date).

 

	
  

	
o

	
In addition, CAD products may also be returned 12 months after the invoice date for Return Goods Credit only provided that the product has not expired.

 

Cattle, Swine, and Equine Biologicals purchased directly from Pfizer Animal Health may be returned for credit based upon 100% of the customer's prior calendar year's pricing. All other Cattle, Swine, and Equine products will receive credit based upon 90% of the customer's prior calendar year's pricing.

 

	
  

	
o

	
Exception #1: Short dated products (defined as consistently shipping with 4-6 months dating or less, such as ScourGuard) may receive a return goods credit based upon 100% of customer's current year's pricing.

 

	
  

	
o

	
Exception #2: Newly launched products not available the prior year, will follow the return policy as stated above but pricing will be based off of the current year.

 

Cad Products purchased directly from Pfizer Animal Health may be returned for credit at 75% of current list price or be exchanged for like product in full packaged quantities provided they are within the return window.

 

	
  

	
o

	
Exception #1: Customers that receive discount pricing due to a contract may have terms per their contract stating they will receive returns pricing at 75% of invoice price.

 

Products sold on a non-returnable basis are not eligible for credit or exchange. Products sold on a non-returnable basis include: syringes, rabies tags, Unipet Nutritabs, Roccal-D, Plastic Dispensing Bags, Sterile Water, Terramycin-343, Terramycin Soluble Powder, Eazi-Breed CIDR, Lincomix Soluble Powder, Lincomix Feed, Neomix 325 Commercial Grade, LS 50,-and MGA

 

A.           Products NOT eligible for exchange include:

 

1           Products not purchased directly from Pfizer Animal Health

 

2           Cattle, Swine, and Equine Products

 

3           Products outside the defined return window

 

4           Items returned in less than the original packaged unit (partials)

 

B.           Products NOT eligible for credit include:

 

1           Products not purchased directly from Pfizer Animal Health

 

2           Products outside the defined return window

 

	
  

	
3

	
Items returned in quantities less than the original packaged unit (partials), with the exception of small animal biologicals, Amoxi tablets, Clavamox tablets, Alban tablets, Primor, Zeniquin, Cestex, Anipryl, and Temaril-P. Partial returns of these items will be credited in 25% increments.

 

C.           Claims for Breakage or Shortage - Any obvious breakage or shortage must be brought to the attention of Pfizer Animal Health and the carrier. This must also be noted when signing delivery documents. Mis-shipments, shortages and concealed damages must be reported to Pfizer Animal Health within 15 business days for distribution (21 days for Veterinarians) from invoice date to receive full invoice credit. Claims received after this timeframe will not be considered for credit. Credits for damages and mis-shipments (i.e. CSR or warehouse error) will be matched up to the original invoice and credited at full invoice pricing.

 

D.           Discontinued Products - Discontinued products may not be returned for exchange but can be returned for credit at our current return's price. Return of discontinued product must meet all other return requirements detailed in this policy.

 

PROCEDURE

 

Pfizer AH Customer Service will make pick up arrangements for returns of outdated product purchased directly from Pfizer. Veterinarians or Pfizer Territory Mangers should contact Customer Service to arrange for pick-up at 1-800-733-5500. Returns for all other classes of trade should be sent freight prepaid to the Pfizer Returns Center located in Lee's Summit, MO.

 

Customer Service and/or Pfizer Animal Health Territory Manager must complete the Merchandise Return Form (MRF) and forward along with the return shipment to the Pfizer Animal Health Returns Center at One Pfizer Way, Building 200, Lee's Summit, MO 64081. The MRF should be marked as credit or exchange. If the return shipment contains both product to be credited, and also product to be exchanged, a separate MRF should be completed for the credit and the exchange. Credit or exchange will be issued only upon receipt of the product at the Pfizer Animal Health Returns Center. Product should not be destroyed in the field. The product must have been purchased directly from Pfizer Animal Health and within the defined returns window.

 

Distributor accounts should fax a copy of the completed MRF to Major Accounts at 1-800-228-5176 for returns authorization. Once approved, a copy of the signed form will be faxed back to the distributor to be included in the return shipment.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00192-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00192-of-00352.parquet"}]]